Details up front: orforglipron · tirzepatide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
All questions
Newest first. 5.2k questions across 107 tags.
Stated plainly: dulaglutide · 98.8%. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it…
What I am working with: dulaglutide · two weeks · minus 20 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody…
What I am working with: BCH · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources…
What I have: four · 1,200 kcal. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable version,…
Numbers first: 96.4% · orforglipron · QYB. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Concretely: a sterility test · orforglipron. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
Details up front: 96.4% · list of related substances. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Costs, fees and monitoring all included, I am trying to compare like with like. I can predict the outcome but I cannot explain it, which means I will get the next…
What I am working with: ApoB · orforglipron. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
Details up front: 96.4% · Janoshik · 97.6% · Medutest. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Details up front: a GLP-1 receptor agonist · 40 °C. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the…
Details up front: 30 mg · 2.5 mL. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is what…
Details up front: WWB · Guangzhou · Japan. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Numbers first: mazdutide · 2.5 mg/mL · two weeks. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the…
What I have: 99.1% · retatrutide · QYB. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
The case in front of me: 99.4% · VendorInvestigate · 98.4% · Janoshik. I would like the axes of comparison first and the recommendation second. I have tried the first…
The case in front of me: 4 mg/mL · oral semaglutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
The case in front of me: aspartimide formation · liraglutide · 25 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What…
Conditions: semaglutide · 3.33 mg/mL · ten weeks. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at…
Stated plainly: semaglutide · Tianjin. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…
The method section is present, which is unusual enough that I want to make use of it. I want to know whether this is a real physical effect or an artefact of how it…
Setup, so nobody has to ask: peptide mapping · survodutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments…
The specifics, since they change the answer: SURMOUNT-1 · tirzepatide. Somebody stated this to me confidently and I would like to check it before repeating it. I…